Last reviewed · How we verify
NCT04752449
Virtual Cognitive Behavioural Therapy for Psychosis
NA trial testing Virtual Cognitive Behavioural Therapy for Psychosis in Psychotic Disorders in 70 participants. Completed in 10 January 2025.
26 January 2024
Quick facts
| Lead sponsor | University of Toronto |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 February 2021 |
| Primary completion | 26 January 2024 |
| Estimated completion | 10 January 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Virtual Cognitive Behavioural Therapy for Psychosis
Conditions studied
- Psychotic Disorders — all drugs for Psychotic Disorders →
- Schizophrenia — all drugs for Schizophrenia →
Sponsor
University of Toronto
Who can join
Adults 18 to 65, any sex, with Psychotic Disorders or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Participants with schizophrenia-spectrum disorders who are experiencing active symptoms of psychosis will randomized to either receive 6 months of individual cognitive behavioural therapy for psychosis or to receive treatment as usual. Participants will be assessed at baseline, 6 months, and 12 months.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Therapist- and client-rated therapeutic alliance in virtual cognitive behavioral therapy for psychosis: Correlates of alliance and associations with treatment outcomes.
Woolridge SM, Vincent NA, Leibovitz T, Jagtap S, et al · · 2026 · PMID 42036783 · DOI 10.1080/10503307.2026.2661045
Verify or expand the search:
- PubMed search for NCT04752449
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychotic Disorders
Currently open trials in the same condition.
- NCT07460453 — Racial Disparities in the Expression of Paranoia · NA · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
- NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting
Other University of Toronto trials
Trials by the same sponsor.
- NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
- NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
- NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04752449 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Toronto
- Last refreshed: 29 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04752449.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing